A pending lawsuit between Churchill Downs, Inc. and the Horseracing Integrity and Safety Authority reached a partial settlement March 24, but issues remain about fees assessed by HISA to tracks owned ...
DENVER - TriSalus Life Sciences Inc. (NASDAQ:TLSI) announced today the publication of preclinical research in Frontiers in Oncology evaluating its Pressure-Enabled Drug Delivery technology for ...
TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models TriSalus Life ...
DENVER--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology company integrating novel delivery technology with standard of care therapies, and its investigational ...
Trisalus Life Sciences, Inc. ((TLSI)) has held its Q4 earnings call. Read on for the main highlights of the call. TriSalus Life Sciences’ latest earnings call carried a clearly upbeat tone, with ...
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) is among the 11 Fastest Growing Penny Stocks to Buy Right Now. On March 6, 2026, Canaccord analyst William Plovanic lowered the price target on TriSalus Life ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
On March 6, 2026, Canaccord analyst William Plovanic lowered the price target on TriSalus Life Sciences, Inc. (NASDAQ:TLSI) to $7 from $12 previously and maintained a Buy rating. William Plovanic said ...
On March 6, 2026, Canaccord analyst William Plovanic lowered the price target on TriSalus Life Sciences, Inc. (NASDAQ:TLSI) to $7 from $12 previously and maintained a Buy rating. William Plovanic said ...
Revenue growth of 53% for the full year 2025 was driven by consistent execution in liver embolization and the strategic expansion of the TriNav product suite into new indications. Management is ...
TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology focused medical technology company advancing novel drug delivery technologies alongside standard-of-care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results